Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study

Autor: Philip J. Asherson, Lena Johansson, Rachel Holland, Megan Bedding, Andrew Forrester, Laura Giannulli, Ylva Ginsberg, Sheila Howitt, Imogen Kretzschmar, Stephen M. Lawrie, Craig Marsh, Caroline Kelly, Megan Mansfield, Clare McCafferty, Khuram Khan, Ulrich Müller-Sedgwick, John Strang, Grace Williamson, Lauren Wilson, Susan Young, Sabine Landau, Lindsay D. G. Thomson

Publikováno v: Asherson, P J, Johansson, L, Holland, R, Bedding, M, Forrester, A, Giannulli, L, Ginsberg, Y, Howitt, S, Kretzschmar, I, Lawrie, S M, Marsh, C, Kelly, C, Mansfield, M, McCafferty, C, Khan, K, Muller-Sedgwick, U, Strang, J, Williamson, G, Wilson, L, Young, S, Landau, S & Thomson, L D G 2022, ' Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study ', British Journal of Psychiatry . https://doi.org/10.1192/bjp.2022.77

BackgroundResearch has shown that 20–30% of prisoners meet the diagnostic criteria for attention-deficit hyperactivity disorder (ADHD). Methylphenidate reduces ADHD symptoms, but effects in prisoners are uncertain because of comorbid mental health

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ab3f8671264adf7eedb1ed06f04f1d
https://doi.org/10.1192/bjp.2022.77